LSCGX
Price
$22.26
Change
-$0.19 (-0.85%)
Updated
Aug 29 closing price
Net Assets
135.51M
RPEBX
Price
$69.18
Change
-$0.47 (-0.67%)
Updated
Aug 29 closing price
Net Assets
158.54B
Interact to see
Advertisement

LSCGX vs RPEBX

Header iconLSCGX vs RPEBX Comparison
Open Charts LSCGX vs RPEBXBanner chart's image
Loomis Sayles Global Growth C
Price$22.26
Change-$0.19 (-0.85%)
VolumeN/A
Net Assets135.51M
American Funds New Perspective R2E
Price$69.18
Change-$0.47 (-0.67%)
VolumeN/A
Net Assets158.54B
LSCGX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LSCGX vs. RPEBX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSCGX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 159B vs. LSCGX (136M). RPEBX pays higher dividends than LSCGX: RPEBX (0.12) vs LSCGX (0.00). LSCGX was incepted earlier than RPEBX: LSCGX (9 years) vs RPEBX (11 years). LSCGX (2.13) is less costly to investors than RPEBX (1.21). RPEBX is a more actively managed with annual turnover of: 24.00 vs. LSCGX (6.00). RPEBX has a lower initial minimum investment than LSCGX: RPEBX (250) vs LSCGX (2500). LSCGX annual gain was more profitable for investors over the last year : 26.48 vs. RPEBX (11.18). LSCGX (29.17) and RPEBX (27.94) have equivalent 5 years return.
LSCGXRPEBXLSCGX / RPEBX
Total Expense Ratio1.951.21161%
Annual Report Gross Expense Ratio2.131.21176%
Fund Existence9 years11 years-
Gain YTD16.92714.593116%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets136M159B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year26.4811.18237%
Returns for 3 years70.0842.79164%
Returns for 5 years29.1727.94104%
Returns for 10 yearsN/A95.08-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRL5.280.09
+1.70%
Scully Royalty Ltd
ESPR2.220.01
+0.45%
Esperion Therapeutics
UHS181.580.36
+0.20%
Universal Health Services
AVDX9.940.01
+0.10%
AvidXchange Holdings
SBEV1.67-0.11
-6.44%
Splash Beverage Group